Cellectar Biosciences - 13 Year Stock Price History | CLRB
Historical daily share prices for Cellectar Biosciences since 2005 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Cellectar Biosciences as of August 21, 2018 is 2.71.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.011B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $122.465B | 18.95 |
| Abbott Laboratories (ABT) | United States | $113.540B | 23.79 |
| Stryker (SYK) | United States | $63.571B | 24.56 |
| Boston Scientific (BSX) | United States | $47.586B | 24.75 |
| Baxter (BAX) | United States | $38.489B | 26.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.204B | 16.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.640B | 0.00 |
| ResMed (RMD) | United States | $15.244B | 30.25 |
| Perrigo (PRGO) | Ireland | $9.983B | 14.17 |
| Bio-Rad Laboratories (BIO) | United States | $9.444B | 60.64 |
| Canopy Growth (CGC) | Canada | $7.445B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.341B | 21.51 |
| ICU Medical (ICUI) | United States | $6.026B | 40.83 |
| Haemonetics (HAE) | United States | $5.351B | 48.83 |
| Insulet (PODD) | United States | $5.209B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $4.408B | 0.00 |
| Neogen (NEOG) | United States | $4.360B | 69.38 |
| Hutchison China MediTech (HCM) | China | $3.903B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.778B | 0.00 |
| NuVasive (NUVA) | United States | $3.598B | 34.13 |
| National Vision Holdings (EYE) | United States | $3.054B | 67.43 |
| Quidel (QDEL) | United States | $2.769B | 56.74 |
| Phibro Animal Health (PAHC) | United States | $1.990B | 29.55 |
| NxStage Medical (NXTM) | United States | $1.846B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.249B | 751.20 |
| Eagle Pharmaceuticals (EGRX) | United States | $1.176B | 34.73 |
| VAREX IMAGING (VREX) | United States | $1.130B | 18.47 |
| AtriCure (ATRC) | United States | $1.099B | 0.00 |
| Omeros (OMER) | United States | $1.016B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.001B | 65.44 |
| Owens & Minor (OMI) | United States | $0.990B | 10.59 |
| Surmodics (SRDX) | United States | $0.981B | 118.47 |
| TG Therapeutics (TGTX) | United States | $0.957B | 0.00 |
| Cerus (CERS) | United States | $0.922B | 0.00 |
| PetIQ (PETQ) | United States | $0.847B | 29.00 |
| MacroGenics (MGNX) | United States | $0.845B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.716B | 34.34 |
| Meridian Bioscience (VIVO) | United States | $0.632B | 21.59 |
| Insys Therapeutics (INSY) | United States | $0.574B | 0.00 |
| Evolus (EOLS) | United States | $0.527B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.515B | 16.01 |
| NanoString Technologies (NSTG) | United States | $0.417B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.363B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.325B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.324B | 20.86 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| Surface Oncology (SURF) | United States | $0.279B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.216B | 0.00 |
| Chimerix (CMRX) | United States | $0.195B | 0.00 |
| Fonar (FONR) | United States | $0.170B | 10.34 |
| Bovie Medical (BVX) | United States | $0.161B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.158B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.119B | 0.00 |
| Female Health (VERU) | United States | $0.115B | 0.00 |
| United-Guardian (UG) | United States | $0.086B | 18.83 |
| Trinity Biotech (TRIB) | Ireland | $0.085B | 25.25 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.082B | 0.00 |
| Neurotrope (NTRP) | United States | $0.075B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.064B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.064B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.036B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.032B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.025B | 0.00 |
| Myomo (MYO) | United States | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.021B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.015B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
